Spots Global Cancer Trial Database for Physiologic MR Imaging of Salivary Gland Tumors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Physiologic MR Imaging of Salivary Gland Tumors

Official Title: Physiologic MR Imaging in Distinguishing Benign From Malignant Salivary Gland Tumors

Study ID: NCT04452162

Conditions

Salivary Gland Tumor

Interventions

MRI

Study Description

Brief Summary: The goal of this study is to use advanced Magnetic Resonance Imaging (MRI) techniques to help identify the difference between cancerous and non-cancerous salivary gland tumors for improving treatment strategies and to aid in the prediction of disease progression.

Detailed Description: The goal of this proposed study is to investigate the potential utility of combined analysis of parameters (Ktrans, ti and ADC) in discriminating benign from malignant salivary glands tumors (SGTs). A total of 30 treatment naïve patients suspicious of SGT as observed on clinical evaluation and prior routine CT, MRI, Ultrasound, FNAC and/or PET will undergo 3T MRI. The MRI protocol will include acquisition of anatomical images with and without contrast agent injection, diffusion imaging and dynamic contrast enhanced-MRI.